INSIGHTS

Research and practical buying guidance.

Browse practical buyer, technical, regulatory and evidence-led guidance across the VEMERIX knowledge library.

LATEST ARTICLES

Practical guidance from the VEMERIX team.

VEMERIX regulatory guide cover on a missing EUDAMED device record in October 2026: the 12-month continued-placement window and the separate 18-month certificate upload.
Is a Missing EUDAMED Device Record Still Allowed?If the first EU unit of a UDI-DI was placed before 28 May 2026, Regulation (EU) 2024/1860 gives the manufacturer 12 months from the functionality notice to enter the device record. The Commission graphic prints 28 November 2026. A first unit placed on or after 28 May 2026 needs the record first.October 3, 2026 · 22 min read
ANVISA Brazil medical device market placement and regulatory compliance roadmap under RDC 751/2022, RDC 848/2024, detentor responsibilities, Solicita subject code 80326, 4-year MDSAP CBPF validity, and IN 290/2024 reliance
Placing a Single-Use Medical Device in Brazil: The 2026 ANVISA RouteAn operational regulatory guide for international medical device distributors, OEM buyers, and foreign manufacturers placing sterile single-use devices on the Brazilian market under RDC 751/2022, RDC 848/2024, the 14 August 2026 Código Único transition, 4-year MDSAP CBPF validity, IN 290/2024 AREE reliance, and the 2026 SIUD UDI database.September 27, 2026 · 20 min read
VEMERIX buyer guide framework for medical laser fiber reuse boundaries across OEM labeling, FDA 510(o), EU MDR Article 17, and China Order 739
Can a Single-Use Laser Fiber Be Reused?What to accept or send back when a clinic asks to resterilize a labeled single-use 1470 nm fiber, offers a reusable-fiber IFU, or treats a silent GEX title as clearance.September 22, 2026 · 18 min read
China Class II UDI production clock decision tree comparing Announcement 21 remaining Class II, 2023 No. 22 third-batch 103 varieties, and Announcement 15 exemptions
Does This China Class II Shipment Need a UDI YetAn incoming-inspection and regulatory-clock guide for international distributors, OEM/private-label buyers, and hospital procurement leads evaluating Chinese Class II sterile device shipments, Announcement 21 remaining-variety deadlines, the 103 third-batch catalogue, and Announcement 15 exemptions on 18 September 2026.September 18, 2026 · 16 min read
Buyer-guide cover for incoming 1470 nm laser fiber safety file audit: fiber carton versus generator carton, FDA Rec 12-356, Rec 12-268 sunset, Laser Notice 56, and GB 9706.222
Which Laser-Safety File Belongs With a 1470 nm Fiber ShipmentAn incoming-inspection and supplier-qualification guide for international medical-device distributors, hospital clinical-engineering leads, and OEM buyers evaluating Chinese 1470 nm endovenous laser fiber shipments, partner-supplied generators, IEC 60601-2-22 editions, Laser Notice 56, and GB 9706.222 on 17 September 2026.September 17, 2026 · 18 min read
Buyer-guide cover for incoming Chinese electrical-safety CoA identity: GB 9706.1-2007, GB 9706.1-2020, FDA Rec 19-49, and EU MDR overlay gates
When a GB 9706.1 CoA Is Not IEC 60601-1 Edition 3.2An incoming-inspection and supplier-qualification guide for international medical-device distributors, hospital procurement teams, and OEM buyers evaluating Chinese electrical-safety certificates, GB 9706.1-2020 transition rules, and FDA or EU regulatory overlays on 16 September 2026.September 16, 2026 · 16 min read
VEMERIX technical guide cover illustrating the buyer audit workflow for a medical device supplier's design and development file under FDA QMSR 21 CFR Part 820, ISO 13485 Clause 7.3, CP 7382.850, EN ISO 13485, and GB/T 42061-2022.
How to Review a Supplier's Design and Development File After QMSRAn incoming audit guide for medical device distributors, OEMs, and private-label partners: why 21 CFR 820.30 is reserved under QMSR, how ISO 13485:2016 Clause 7.3 carries the legal duties, what CP 7382.850 inspects under Design and Development, how EN ISO 13485 and GB/T 42061-2022 overlay the file, the DHF-to-medical-device-file pivot, and an 8-point buyer acceptance protocol.September 15, 2026 · 16 min read
Buyer-guide cover for incoming Chinese EO CoA identity: GB 18279.1-2015, GB 18279-2023, FDA Rec 14-529, and EN ISO 11135 overlay gates
When a Chinese EO CoA Is Not an ISO 11135 Cycle FileAn incoming-inspection and supplier-qualification guide for international medical-device distributors, hospital procurement teams, and OEM buyers evaluating Chinese ethylene oxide sterilization certificates, GB 18279 edition shifts, and FDA or EU cycle-file overlays in September 2026.September 14, 2026 · 15 min read
When a Sample Lot Is Not the Commercial Lot in Ethylene Oxide Sterilization: ISO 11135:2014 cycle baseline, FDA Rec 14-529, AAMI TIR28:2016/(R)2020 under FDA Rec 14-603, Annex E single-batch release distinction, and commercial load adoption rules
When a Sample Lot Is Not the Commercial Lot: Why an ISO 11135:2014 Cycle File and FDA Rec 14-529 Do Not Adopt a New Size, Blister or Load, Why AAMI TIR28 Rec 14-603 Is the Product-Adoption Overlay, Why Annex E Single-Batch Release Is Not Adoption, and Why ISO/FDIS 11135 Is Not the Cycle FileAn incoming-inspection and supplier-qualification guide for international medical-device distributors, hospital buyers, and OEM engineers navigating ethylene-oxide cycle certificates, product adoption, single-batch release, and commercial pallet density across the US FDA, ISO, and AAMI frameworks in September 2026.September 12, 2026 · 19 min read
Remaining shelf life on sterile medical devices in 2026: FDA April 1991, 21 CFR 801.18 date format, EU MDR GSPR 11.4 sterility until opened, UNICEF October 2023 two-thirds rule and five-year floor, WHO TRS 1044 Annex 8 months table, and ISO 11607 packaging boundary
When a Tender Demands 75 Percent or 80 Percent Remaining Shelf Life on a Sterile Device: Why FDA April 1991 and EU MDR GSPR 11.4 Do Not Set a Remaining-Percentage Statute, Why UNICEF October 2023 Uses Two Thirds and a Five-Year Floor, Why WHO TRS 1044 Annex 8 Is a Months Table After Risk Assessment, and Why ISO 11607 Is Not the Dock ClockAn operational procurement and regulatory guide for international medical-device distributors, hospital buyers, and OEM sellers navigating remaining-shelf-life tender clauses, incoming-inspection dock tests, and labelled expiration dates across the US, EU, UNICEF, and WHO frameworks in September 2026.September 11, 2026 · 18 min read
ISO 11607 packaging declaration of conformity recognition in 2026: ISO 11607-1/2:2019 including Amendment 1:2023, US FDA Rec 14-594 and 14-595 versus Rec 14-530 and 14-531, EU Decision 2024/815, and China GB/T 19633.1-2024
Which ISO 11607 Packaging Declaration of Conformity Survives 20 December 2026: Why FDA Rec 14-594 and 14-595 Name 2019 Including AMD1:2023, Why Rec 14-530 and 14-531 Remain Acceptable Until That Date, Why Decision (EU) 2024/815 Already Cites EN ISO 11607-1:2020/A1:2023, and Why GB/T 19633.1-2024 Is the 2019 IDT Implemented 1 December 2025An operational technical and regulatory guide for international medical-device distributors, OEM buyers, and quality engineers evaluating sterile-barrier packaging validation files, declarations of conformity, and recognition timelines across the US, EU, and China in September 2026.September 10, 2026 · 17 min read
Which ISO 10993-7 edition governs an EO residual CoA in 2026: ISO 10993-7:2026 third edition publication versus US FDA Recognition Number 2-275, EU MDCG 2024-13, and China GB/T 16886.7-2015
Which ISO 10993-7 Edition Governs an EO Residual CoA in 2026: Why ISO 10993-7:2026 Is Not FDA Recognition 2-275, Why the 25 May 2026 Part 1 Update Did Not Move Part 7, and Why MDCG 2024-13 Still Names EN ISO 10993-7:2008+A1:2022An operational technical and regulatory guide for international medical-device distributors, OEM buyers, and quality engineers evaluating EO-sterilized single-use device residual certificates of analysis, dissipation curves, and regulatory recognition across the US, EU, and China in 2026.September 9, 2026 · 16 min read